HTLV Resource Center
HTLV Detection Kits and Automated Systems
HTLV Blood Virus Screening
AABB recommends the dual enzyme immuno assay (EIA) approach for deferral and notification of Anti-HTLV-I/II EIA reactive donors. The #99-9 bulletin listed by the AABB and 21CFR 640.10.e clearly states that reactive unit should be further tested whenever a supplemental (additional, more specific) test has been approved for such use by FDA.
Dual Enzyme EIA Algorithm
The health information contained herein is provided for educational, reference purposes only, and is not intended to substitute professional medical advice, diagnosis, or treatment with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product is currently not available for the US market. Please check the availability and relevance of the information in your respective country.